Loading organizations...
HealthReveal is a technology company.
HealthReveal develops a clinical artificial intelligence platform that delivers personalized, data-driven recommendations for managing chronic diseases. The platform leverages advanced analytics and remote monitoring to preempt avoidable health complications, enabling proactive interventions. Its core functionality focuses on optimizing care pathways and delivering precise guidance to improve patient outcomes.
The company was founded in 2015 by Mark Keim and Frank Norman, who identified the need for a more predictive and personalized approach to chronic disease management. Their insight centered on harnessing clinical data to move beyond reactive care, aiming instead to anticipate and mitigate health declines before they manifest.
HealthReveal serves healthcare payers and providers, equipping them with tools to ensure patients receive clinically optimal treatments. The company's long-term vision is to significantly enhance the quality of life for individuals with chronic conditions while simultaneously driving down healthcare costs through intelligent, preventative care strategies.
HealthReveal has raised $11.0M across 1 funding round.
HealthReveal has raised $11.0M in total across 1 funding round.
HealthReveal is a clinical AI company that develops cloud-based analytics platforms to deliver personalized, data-driven recommendations for patients with chronic diseases, helping clinicians predict health risks, monitor progression, and apply guideline-directed medical therapy (GDMT).[1][2][3] It serves payors, providers, self-insured employers, and clinicians by preempting adverse events, improving care quality, reducing costs, and enhancing quality of life—applications like "Reveals Access" and "NLP Review" provide real-time patient data access, dashboards, and therapy recommendations.[1][2][5] Founded in 2015, the company raised $26.6M before its acquisition by Accolade, Inc. in October 2021, marking strong growth momentum validated by early MVPs and partnerships.[3][4]
HealthReveal was founded in 2015 in New York, New York, as a healthcare technology startup (formerly 2015 Holdco) focused on chronic disease management amid rising complexities in patient data and medical guidelines.[2][3][6] Key early funding included a $10.8M Series A in February 2017 led by Flare Capital Partners, GE Ventures, Greycroft Partners, and Manatt Ventures, plus extensions totaling over $26M, enabling platform development.[3][4] A pivotal moment came in 2020 when Remedy Product Studio built a fully functioning MVP of Reveals Access in three months using React and Node.js, incorporating agile practices, HIPAA compliance, and features like real-time data dashboards—this accelerated traction, leading to two predictive tools and the 2021 acquisition by Accolade.[1] These steps humanized its mission to bridge patient data with evolving medical knowledge.
HealthReveal stands out in clinical AI through:
HealthReveal rides the AI-driven chronic care wave, addressing an aging population's chronic disease burden where human analysis of expanding data and guidelines falls short—market forces like rising healthcare costs and value-based care favor its predictive interventions.[2][3] Timing aligned with 2010s AI advancements in healthcare, post-2015 founding amid IoT and ML growth, positioning it ahead of competitors like OM1 and Medial EarlySign in guideline automation.[3] Post-acquisition, it influences ecosystems via Accolade collaborations (e.g., ACC's TRANSFORM HFrEF trials embedding Reveals in EHRs) and real-world evidence generation, accelerating personalized medicine adoption.[1][3]
Integrated into Accolade since 2021, HealthReveal's platform will likely expand via larger-scale EHR integrations and trials, leveraging AI for novel chronic care insights amid trends like real-world evidence and predictive analytics.[1][2][3] Evolving regulations on AI in healthcare and payer shifts to outcomes-based models will shape its trajectory, potentially amplifying Accolade's chronic disease offerings. Its influence may grow by setting standards for guideline-directed AI, preempting consequences in an era of complex medicine—echoing its core mission to save lives through optimal, personalized care.[2]
HealthReveal has raised $11.0M in total across 1 funding round.
HealthReveal's investors include GE Ventures, Bessemer Venture Partners, Binary Capital, Flare Capital Partners, Founder Collective, Mohamad Makhzoumi, Greycroft, Manatt.
HealthReveal has raised $11.0M across 1 funding round. Most recently, it raised $11.0M Series A in February 2017.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2017 | $11.0M Series A | GE Ventures | Bessemer Venture Partners, Binary Capital, Flare Capital Partners, Founder Collective, Mohamad Makhzoumi, Greycroft, Manatt |